Riding the pepTIDE — The Daily Wire on Therapeutic Peptides

An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.

Topic Sections

  • Top Shots — The most significant peptide and longevity stories ranked by overall editorial score
  • Research Signals — High-credibility scientific findings from journals, preprints, and clinical sources
  • Healing & Recovery — Tissue repair, injury recovery, and gut healing peptides including BPC-157 and TB-500
  • Growth Hormone Wire — Growth hormone secretagogues, peptide stacks, and GH axis research including Ipamorelin, CJC-1295, and MK-677
  • Metabolic & GLP-1 — Metabolic health, insulin sensitivity, and GLP-1 receptor agonist research including semaglutide and tirzepatide
  • Cognitive / Nootropic — Peptides targeting brain function, memory, neuroprotection, and cognitive enhancement
  • Skin & Cosmetic — Skin repair, anti-aging, collagen synthesis, and cosmetic peptide research including GHK-Cu and matrixyl
  • Reddit Finds — Community-sourced discussions, self-experimentation reports, and protocol threads from peptide communities
  • Contrarian Takes — Alternative viewpoints, dissenting research, and perspectives that challenge mainstream peptide narratives
  • Skeptic's Corner — Hype debunking, low-evidence alerts, and critical analysis of overstated peptide claims

Browse by Filter

  • Newest — Latest peptide and longevity stories
  • Most Credible — Highest credibility-scored stories
  • Most Edgy — High-novelty, unconventional findings
  • Most Discussed — Trending community discussions
  • Most Actionable — Direct applicability to daily health protocols
  • Lowest Risk — Stories with strong evidence, low hype
  • Research Only — Peer-reviewed and preprint studies
  • Reddit Only — Community discussion and anecdote
  • GLP-1 / Metabolic — Semaglutide, tirzepatide, and metabolic peptides
  • Healing / Recovery — BPC-157, TB-500, and repair protocols

More

  • About Riding the pepTIDE
  • Health Disclaimer
  • Submit a Source
  • Contact

Does a Growth-Hormone Pill Harm Male Sexual Function? Early Questions Remain

A short answer up front: someone asked whether MK-677 causes erectile dysfunction, and a piece on Portal CNJ raised the question. The article is basically a discussion about reports and concerns, not a definitive clinical trial. It flags that people taking MK-677 (also called ibutamoren) have reported sexual side effects, but the evidence is mixed and mostly informal. MK-677 is a lab-made compound that stimulates the body’s growth hormone system. It is not a hormone itself; instead it tricks the brain into releasing more growth hormone and a related hormone called IGF-1. People use it for reasons like trying to increase muscle, improve sleep, or counteract age-related decline in growth hormone. It has been sold as a research chemical and is not an approved prescription drug for most uses. What the available reporting and studies actually show is murky. There are some small clinical studies looking at hormone levels and safety that show MK-677 raises growth hormone and IGF-1. Reports about erectile dysfunction come mainly from anecdotal user reports and small, sometimes uncontrolled studies that weren’t designed to measure sexual function. A few people have said they experienced decreased libido or erection problems while taking it, but larger, well-controlled trials that specifically track sexual side effects are scarce. That means we can’t say for sure how common or how directly caused these symptoms are. Why this matters is straightforward: erectile dysfunction affects quality of life and can be a sign of other health problems. People considering MK-677—especially men using it off-label for muscle or anti-aging benefits—should know there are reports of sexual side effects. If true and common, those effects could outweigh potential benefits for some users. Doctors, people with preexisting sexual dysfunction, and anyone taking other medications that affect hormones or blood flow would care about reliable information here. There are important caveats. MK-677 is not approved by major regulators for general use and is often sold without medical oversight. Side effects that have been reported in studies include increased appetite, water retention, and changes in glucose (blood sugar) levels; how these relate to sexual function is uncertain. People with diabetes, heart disease, or hormone-sensitive conditions should be cautious. Because much of the “evidence” about erectile problems is anecdotal, we need better controlled studies that specifically ask about sexual health before drawing firm conclusions. If someone experiences new sexual side effects while using MK-677, they should stop and consult a healthcare professional. Bottom line: there are reports linking MK-677 to erectile problems, but the evidence is limited and inconclusive, so caution and medical advice are warranted.

Source: Portal CNJ

Read full story

Back to Riding the pepTIDE